Sprint Bioscience (Sweden) Profile

14.00
SEK 0.05  0.36%
93%
100%

Sprint Bioscience Summary

Sprint Bioscience AB (SPRINT) is traded on Stockholm Stock Exchange in Sweden. It is located in Novum and employs 11 people. The company currently falls under 'Small-Cap' category with current market capitalization of 136.35 M. Sprint Bioscience AB operates under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 10.1 M outstanding shares. SPRINT BIOSC has accumulated about 1.48 M in cash with (23.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19.
Check Sprint Bioscience Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 14.0HorizonTargetOdds Above 14.0
84.09%30 days 14.00 15.72%
Based on normal probability distribution, the odds of Sprint Bioscience to move above current price in 30 days from now is about 15.72% (This Sprint Bioscience AB probability density function shows the probability of Sprint Bioscience Stock to fall within a particular range of prices over 30 days) .

Sprint Bioscience AB Risk Profiles

Key Fundamentals

Sprint Bioscience Against Markets

Current Ratings

Sprint Bioscience 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
13 
Chance of
Financial Distress (0 to 100%)
41 
Equity ratings for Sprint Bioscience AB are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Sprint Bioscience AB develops pharmaceutical products in the areas of cancer and metabolism. Sprint Bioscience AB was founded in 2009 and is based in Huddinge, Sweden. Sprint Bioscience operates under Pharmaceuticals And Biosciences classification in Sweden and traded on Stockholm Stock Exchange. more
NameSprint Bioscience AB
CEOAnders AbergView All
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentSweden Stock View All
Business AddressNovum
ExchangeStockholm Stock Exchange
ISINSE0006343745
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.sprintbioscience.com
Phone46 84 11 44 55
CurrencySEK - Swedish Kronor

Sprint Bioscience Corporate Directors

AnneMarie Wenthzel Director of Sales and Marketing
Martin Andersson Founder and Director of Discovery Projects
Ingemar Kihlstrom Director
Also please take a look at World Market Map. Please also try Money Managers module to screen money managers from public funds and etfs managed around the world.